TME PHARM.CONF.IPO EO 1- (0N6A) — Defensive Interval Ratio
TME PHARM.CONF.IPO EO 1- (0N6A) has a Defensive Interval Ratio of 1 days as of December 2025. Defensive assets of €6.00K (cash €-, short-term investments €4.00K, receivables €2.00K) cover 1 days of daily cash needs of €10.19K/day.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
TME PHARM.CONF.IPO EO 1- Defensive Interval Ratio (2021–2025)
This chart shows how TME PHARM.CONF.IPO EO 1-'s Defensive Interval Ratio has evolved across 3 annual periods from 2021 to 2025. As of December 2025, the ratio stands at 1 days, meaning defensive assets of €6.00K can fund 1 days of operations without new revenue. For the complete balance sheet picture, see how large is TME PHARM.CONF.IPO EO 1-'s balance sheet.
Annual Defensive Interval Ratio for TME PHARM.CONF.IPO EO 1- (2021–2025)
The table below presents the year-by-year Defensive Interval Ratio for TME PHARM.CONF.IPO EO 1- from 2021 to 2025, covering 3 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. See TME PHARM.CONF.IPO EO 1- working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
| Year | DIR (days) | Defensive Assets (EUR) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 1 days | €6.00K | €10.19K/day | €- | €4.00K | ▼ 0 days |
| 2024 | 1 days | €5.00K | €4.91K/day | €- | €5.00K | ▼ -1 days |
| 2021 | 2 days | €28.00K | €14.43K/day | €- | €28.00K | — |